Biotech · Private company
Transcenta Therapeutics (Hangzhou) Co., Ltd.
Track this companyFree. Adds Transcenta Therapeutics (Hangzhou) Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- Albumin-Bound PaclitaxelPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- mFOLFOX6Phase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Nivolumab Injection [Opdivo]Phase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- TST001Phase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- TST003Phase 2 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- 10 mg/kg Q2W MSB2311 InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- 10 mg/kg Q3W MSB2311 InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- 20 mg/kg Q3W MSB2311 InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- 3 mg/kg Q3W MSB2311 InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TST005Phase 1 · Locally Advanced or Metastatic CancersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 8, 2023ClinicalTrials.gov NCT05731271 · fetched Nov 12, 2026
- Study of TST005 in Patients With Locally Advanced or Metastatic Solid TumorsPHASE1 · TERMINATED · started Jun 11, 2021ClinicalTrials.gov NCT04958434 · fetched Nov 12, 2026
- A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 28, 2020ClinicalTrials.gov NCT04396821 · fetched Nov 12, 2026
- A Phase I Study of MSB2311 in Advanced Solid TumorsPHASE1 · COMPLETED · started Apr 12, 2018ClinicalTrials.gov NCT03463473 · fetched Nov 12, 2026